Health insurance technology platform Health In Tech reiterated its full-year revenue guidance on Thursday following its first-quarter earnings release, while also detailing its 2026 investment plan. Despite a widening net loss in the first quarter, the company has chosen to increase investment to seize market opportunities.

Performance Overview and Outlook Financial results show that Health In Tech's first-quarter revenue reached $8.8 million, a year-over-year increase of 9.4%. However, the company reported a net loss of $1.6 million, or a loss of $0.03 per share, compared to a net profit of $500,000 in the same period last year. Nevertheless, the company reaffirmed its full-year 2026 revenue expectation of $45 million to $50 million, representing growth of approximately 35% to 50% compared to the $33.3 million forecast for 2025. As of the end of the quarter, signed revenue for the remaining three quarters of 2026 totaled $22.9 million, providing visibility toward the annual target.

Strategic Investment Plan The company has designated 2026 as a "year of investment for growth." Management indicated that the approximately $7 million PIPE financing completed in March (involving the issuance of 5.6 million shares at $1.25 per share) will fund sales team expansion, marketing initiatives, new product launches, and technology infrastructure upgrades. In the first quarter, sales and marketing expenses more than doubled year-over-year to $2.3 million, increasing their share of revenue from 14% to 26%.

New Product Development Progress The company is actively advancing a three-year rate stabilization plan, with market testing expected to be completed between the end of the second quarter and the third quarter. Additionally, an analytics solution integrating physiological and claims data is set to begin initial beta testing in the second quarter, aiming to generate actionable insights for clients and create new revenue streams.